A Phase 2 Study of Pracinostat and Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Not Eligible for Induction Chemotherapy: Response and Long-Term Survival Benefit Manero, G., Atallah, E., Khaled, S. K., Arellano, M., Patnaik, M. M., Odenike, O., Sayar, H., Tummala, M., Patel, P. A., Ghalie, R. G., Medeiros, B. C. AMER SOC HEMATOLOGY. 2016

View details for Web of Science ID 000394446803016